share_log

RBC Capital下调安进目标价至330美元

RBC Capital lowers Amgen's target price to $330.

Gelonghui Finance ·  Nov 28, 2024 15:43  · Ratings

November 28th, Glon Finance|RBC Capital: Lowered Amgen's target price from $360 to $330, maintaining an "outperform" rating. (Glon Finance)

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment